Access cutting-edge rectal adenocarcinoma treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Portland location
Preparing your pre-screening questions…
Access rectal adenocarcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rectal adenocarcinoma treatment provided free
Check if you qualify for this rectal adenocarcinoma clinical trial in Portland, OR
No-Cost Study Care
Local to Portland
Convenient for OR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study measures the levels of circulating tumor DNA (ctDNA) in patients with stage II-III rectal cancer before, during, and after treatment to find out if the presence or absence of ctDNA in patient's blood using the Signatera test can be used to gauge how different treatments may affect rectal cancer. ctDNA is DNA from the rectal cancer that is circulating in the blood. The purpose of this study is to understand if the way rectal tumors respond to standard treatment can be associated with varying levels of ctDNA.
Sponsor: OHSU Knight Cancer Institute
Yes, this clinical trial (NCT05081024) has an active research site in Portland, OR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for rectal adenocarcinoma treatment options in Portland, OR, this clinical trial (NCT05081024) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rectal adenocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all rectal adenocarcinoma clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Portland — not just this study.
Browse Alzheimers Disease Trials in Portland →